콘텐츠로 건너뛰기
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Menu
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Get In Touch
PharmCADD signed a co-development agreement of novel anticancer drug discovery with KYNOGEN
News
01/22/2021
<View Original Article>
Post Views:
126
Prev
Previous
PharmCADD will create an innovative AI drug and will be listed on KOSDAQ in March 2022.
Next
[New drug development using AI] Molecular design using generative models
Next